← FDA DRUG APPROVALS

FDA ANDA · ANDA065340

CEFPROZIL

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA065340
TYPE
ANDA
ORIGINAL APPROVAL
2007-05-24
LATEST ACTION
2017-05-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CEFPROZILPrescription
CEFPROZIL 250MG · TABLET · ORAL
CEFPROZILPrescription
CEFPROZIL 500MG · TABLET · ORAL

Approval history

2017-05-15Labeling · Supplement 4 · standardAP
2008-02-05Labeling · Supplement 1AP
2007-05-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →